Literature DB >> 21752897

MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha.

Vincenza Leone1, Daniela D'Angelo, Ileana Rubio, Paula Mussnich de Freitas, Antonella Federico, Marianna Colamaio, Pierlorenzo Pallante, Geraldo Medeiros-Neto, Alfredo Fusco.   

Abstract

CONTEXT: Micro-RNA have emerged as an important class of short endogenous RNA that act as posttranscriptional regulators of gene expression and are constantly deregulated in human cancer. MiR-1 has been found down-regulated in lung, colon, and prostate cancer.
OBJECTIVES: In this study, we investigated the possible role of miR-1 in thyroid carcinogenesis.
DESIGN: We have analyzed miR-1 expression in a panel of thyroid neoplasias including benign and malignant lesions and searched for miR-1 targets.
RESULTS: Our results show that miR-1 expression is drastically down-regulated in thyroid adenomas and carcinomas in comparison with normal thyroid tissue. Interestingly, miR-1 down-regulation was also found in thyroid hyperproliferative nonneoplastic lesions such as goiters. We identified the CCND2, coding for the cyclin D2 (CCND2) protein that favors the G1/S transition, CXCR4, and SDF-1α genes, coding for the receptor for the stromal cell derived factor-1 (SDF-1)/CXCL12 chemokine and its ligand SDF-1/CXCL12, respectively, as miR-1 targets. An inverse correlation was found between miR-1 expression and CXC chemokine receptor 4 (CXCR4) and SDF-1α protein levels in papillary and anaplastic thyroid carcinomas. Consistent with a role of the CCND2 protein in cell proliferation and CXCR4 and SDF-1α proteins in cell invasion and metastasis, functional studies demonstrate that miR-1 is able to inhibit thyroid carcinoma cell proliferation and migration.
CONCLUSIONS: These results indicate the involvement of miR-1 in thyroid cell proliferation and migration, validating a role of miR-1 down-regulation in thyroid carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21752897     DOI: 10.1210/jc.2011-0345

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  57 in total

Review 1.  Deregulation of microRNA expression in thyroid neoplasias.

Authors:  Pierlorenzo Pallante; Sabrina Battista; Giovanna Maria Pierantoni; Alfredo Fusco
Journal:  Nat Rev Endocrinol       Date:  2013-11-19       Impact factor: 43.330

2.  MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug.

Authors:  Eiji Osaka; Xiaoqian Yang; Jacson K Shen; Pei Yang; Yong Feng; Henry J Mankin; Francis J Hornicek; Zhenfeng Duan
Journal:  J Orthop Res       Date:  2014-04-24       Impact factor: 3.494

3.  The role of PI3K signaling pathway and its associated genes in papillary thyroid cancer.

Authors:  Elham Amjad; Solmaz Asnaashari; Babak Sokouti
Journal:  J Egypt Natl Canc Inst       Date:  2021-05-17

4.  MicroRNA-409-3p suppresses cell proliferation and cell cycle progression by targeting cyclin D2 in papillary thyroid carcinoma.

Authors:  Zhijun Zhao; Fei Yang; Yan Liu; Kai Fu; Shanghua Jing
Journal:  Oncol Lett       Date:  2018-08-01       Impact factor: 2.967

Review 5.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

6.  MicroRNA expression profiles in differentiated thyroid cancer, a review.

Authors:  Xinying Li; Asim B Abdel-Mageed; Debasis Mondal; Emad Kandil
Journal:  Int J Clin Exp Med       Date:  2012-11-18

7.  Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis.

Authors:  Lei Wang; Jeffrey Ho; Carlotta Glackin; Manuela Martins-Green
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

8.  MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.

Authors:  Matthias Dettmer; Alexander Vogetseder; Mary Beth Durso; Holger Moch; Paul Komminoth; Aurel Perren; Yuri E Nikiforov; Marina N Nikiforova
Journal:  J Clin Endocrinol Metab       Date:  2012-11-12       Impact factor: 5.958

9.  miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.

Authors:  Pablo Letelier; Patricia García; Pamela Leal; Héctor Álvarez; Carmen Ili; Jaime López; Jonathan Castillo; Priscilla Brebi; Juan Carlos Roa
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 10.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.